Dodla DairyQ2 FY25

Dodla Dairy Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,006P/E: 25.4Market Cap: ₹6.3K CrSector: Food Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

No

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • The company targets a consistent value growth of around 15% CAGR on average going forward, acknowledging seasonal fluctuations in the dairy industry (Sunil Reddy).
  • H1 FY25 already recorded a 20% top-line growth, suggesting a strong current year with possible normalization in subsequent years.
  • Expansion plans include entry and scale-up in Maharashtra with a large integrated plant capable of 10 lakh liters, staged over 15-16 months (BVK Reddy).
  • Africa business volumes have increased, with sales volume rising from 1.11 lakh liters/day in FY24 to 1.78 lakh liters/day in H1 FY25; however, margins dip seasonally (BVK Reddy).
  • Value-added products (VAP) sales continue growing strongly; they constituted 39-40% of sales and are expected to sustain in this range (Sunil Reddy).
  • Milk sales volumes in India grew from 13.47 lakh liters/day (FY24) to 14.13 lakh liters/day in H1 FY25, indicating volume growth momentum (BVK Reddy).
  • The company emphasizes maintaining EBITDA margins in the 9-10% range while focusing on absolute earnings growth.

See what Dodla Dairy management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
  • There is no specific mention of immediate or planned new fundraising through debt or equity.
  • The company has substantial cash on its balance sheet and is currently deploying cash for expansion, notably the Maharashtra plant.
  • Management is open to acquisitions but none are finalized or imminent.
  • Focus is on organic growth and capex, with Maharashtra plant capex spread over FY25 and FY26.
  • Dividends have been declared, including an interim dividend of INR 3 per share, and the company plans to maintain dividend payouts.
  • No explicit indication of raising fresh equity or debt in the near term was provided during the call.

See what Dodla Dairy management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Maharashtra Plant: Dodla Dairy has acquired 35 acres of land in Maharashtra for an integrated manufacturing plant with an initial capacity plan having 2 lakh liters of milk procurement currently, aiming to scale to 7 lakh liters per day over three years.
  • Capex Estimate: Overall project cost for Maharashtra is estimated between INR 200 to 250 crores, to be executed in stages over FY25 and FY26.
  • Timeline: Civil operations to commence by November 2024, with plant commencement targeted around April 2026; major capex expected in FY26.
  • Additional Land: Plans to acquire adjoining land to expand the plant capacity to 10 lakh liters.
  • No Major Investments in Africa: No further capex planned currently in Kenya or Uganda; focus on stabilizing operations.
  • Ongoing Normal Capex: Regular capex in FY25 around INR 43 crores spent in H1, in line with normal trends.
  • Strategic Focus: Potential acquisitions are being explored but no immediate deals finalized.

Track Dodla Dairy — get its next earnings analysis in your feed

How does Dodla Dairy rank vs peers in Food Products?

Pro feature
ThisDodla Dairy
Rev 3Mar 3

How does Dodla Dairy rank in Food Products?

Compare Dodla Dairy against every Food Products company (Q2 FY25) on revenue, margins and earnings-call signals.

View Food Products leaderboard →

Others in Food Products this season

  • Sheetal Cool Products Ltd (Q1 FY27)

    Revenue from Operations for FY26: ₹366.0 Crores, up 13.9% YoY from ₹321.3 Crores in FY25 (Page 29, 5). Key investor presentation takeaways from Sheetal Cool Pro

  • Mukka Proteins Ltd (Q4 FY26)

    Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

  • Mukka Proteins Ltd (Q1 FY27)

    Q1 FY27 Revenue from Operations: ₹489.7 crore . Key concall takeaways from Mukka Proteins Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Shri Ahimsa Naturals Ltd (Q4 FY26)

    Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →